The United States has the largest prescription drug market in the world, yet Americans pay significantly higher prices for medication than most other nations. These exorbitant costs mean that millions struggle to afford essential prescriptions—despite their availability. Shockingly, one in four patients receives a prescription from their doctor only to find that the price is beyond their reach. The financial burden of prescription drug costs extends beyond individuals; it strains taxpayers and seniors, driving up expenses for Medicare and Medicaid. Meanwhile, as Americans face prohibitive drug prices, pharmaceutical companies continue to reap immense profits. In 2022 alone, the ten largest pharmaceutical firms in the U.S. amassed over USD 110 billion in earnings—flourishing while many patients struggle to access the medicine they need. This book examines the systemic forces shaping prescription drug pricing in the United States, exploring transparency, competition, and policy solutions aimed at ensuring fairness and affordability in the marketplace.
